Remission of pure red cell aplasia in T-cell receptor gammadelta-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab

Leukemia. 2005 Nov;19(11):2005-8. doi: 10.1038/sj.leu.2403956.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alemtuzumab
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Genes, T-Cell Receptor delta
  • Genes, T-Cell Receptor gamma
  • Humans
  • Leukemia, T-Cell / complications*
  • Male
  • Red-Cell Aplasia, Pure / drug therapy*
  • Red-Cell Aplasia, Pure / etiology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm
  • Antineoplastic Agents
  • Alemtuzumab